44
Participants
Start Date
April 17, 2023
Primary Completion Date
October 4, 2023
Study Completion Date
October 4, 2023
Voxelotor
Drug drug interaction
Bupropion
Drug drug interaction
Repaglinide
Drug drug interaction
Flurbiprofen
Drug drug interaction
Omeprazole
Drug drug interaction
Midazolam
Drug drug interaction
Metformin
Drug drug interaction
Furosemide
Drug drug interaction
Rosuvastatin
Drug drug interaction
ICON Early Phase Services, LLC, San Antonio
Lead Sponsor
Pfizer
INDUSTRY